# (H.E.L.P.)Apheresis Therapy to Compare the Reduction of LDL (Low Density Lipoprotein) Cholesterol

> **NCT00526058** · NA · COMPLETED · sponsor: **B. Braun Medical Inc.** · enrollment: 18 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DEVICE:** Secura then Futura
- **DEVICE:** Futura then Secura

## Key facts

- **NCT ID:** NCT00526058
- **Lead sponsor:** B. Braun Medical Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2008-10
- **Final completion:** 2008-12
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2018-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00526058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00526058, "(H.E.L.P.)Apheresis Therapy to Compare the Reduction of LDL (Low Density Lipoprotein) Cholesterol". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00526058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*